Dr Sandar Tin Tin
Sandar Tin Tin
MBBS, MPH, PhD
Girdlers’ New Zealand HRC Fellow
Sandar joined the Cancer Epidemiology Unit as a Girdlers’ New Zealand HRC (Health Research Council) Fellow in August 2019. She was trained as a medical doctor in Myanmar and holds a Master of Public Health and a PhD from the University of Auckland, New Zealand.
Sandar has a broad interest in the theoretical, methodological and applied aspects of epidemiological research, and has undertaken a number of research projects related to cancer, active travel, injury and child and youth health. Her current research is based on the UK Biobank and examines physical activity, biomarkers and breast cancer risk.
Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status.
Aye PS. et al, (2020), Cancer Epidemiol, 69
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.
Aye PS. et al, (2020), BMC Cancer, 20
Utilisation and Determinants of Epidermal Growth Factor Receptor Mutation Testing in Patients with Non-small Cell Lung Cancer in Routine Clinical Practice: A Global Systematic Review.
Thi AM. et al, (2020), Target Oncol
Body size and composition, physical activity and sedentary time in relation to endogenous hormones in pre- and post-menopausal women: findings from the UK Biobank
Tin Tin S. et al, (2020), International Journal of Cancer
Increasing incidence of endometrial carcinoma in a high-risk New Zealand community.
Bigby SM. et al, (2020), Aust N Z J Obstet Gynaecol